Regarding serum, the study by Borsche et al. (2020) investigated the sporadic form of PD and found that patients with biallelic PINK1 and Parkin mutations had elevated levels of ccf mtDNA and IL-6, suggesting increased ccf mtDNA release and neuroinflammation in these PD patients [22]. This evidence concerns the gene PRKN and Parkinson disease.